Costcos Quiet Citi Card Benefit Cut Could Cost Members Hundreds Fitness Apps Challenge Personal Trainers Market Disruption or Safety Risk Meta Plans 6065 Billion AI Spending Spree Fueling Data Center Expansion Workday Shares Rise on Improved Margin Outlook Driven by AI Adoption Bessent Anticipates Substantial Disinflation as Warsh Assumes Fed Leadership FII Outflows from Indian Markets May Persist Amid Earnings Growth Concerns Experts Warn BancFirst Corporation BANF Q1 2026 Earnings Strong EPS Beat Driven by Solid Operating Performance LNZA Q4 2025 Earnings Loss Narrower Than Expected Shares Slide CapsoVision CV Q1 2026 Earnings EPS Miss Raises Concerns Amid Operational Uncertainty CalMaine Foods Q1 2026 Earnings EPS Surges Past Estimates on Stable Egg Demand FGBIP Q1 2026 Earnings Earnings Beat Expectations with 96 Surprise Youdao Inc Q1 2026 Earnings EPS Misses Estimates but Stock Surges on Broader Sentiment Apollo Commercial Real Estate Finance ARI Steadies Near Support Amid Modest Decline BOK Financial Slips 15 as Regional Banking Sector Faces Renewed Headwinds Amphastar Pharmaceuticals AMPH Gains 138 as Stock Consolidates Near Key Resistance CCSC Technology CCTG Shows Modest Gains as Stock Hovers Near Resistance SPACSphere Acquisition Corp SSAC Holds Steady at 995 Testing Key Technical Juncture Lyft Under 15 RideHailing Stock Draws Market Attention Bel Fuse Inc BELFB Q1 2026 Earnings EPS Beats Estimates by 888 Despite Stock Decline iRhythm Holdings IRTC Slides 19 as Stock Tests Key Support Zone UTI Q1 2026 Earnings EPS Misses Estimates but Stock Climbs on Positive Indicators WST Q1 2026 Earnings Strong Profit Beat Offsets Revenue Opacity BDX Q1 2026 Earnings Earnings Per Share Exceeds Estimates Stock Holds Steady Bright Horizons BFAM Q1 2026 Earnings EPS Beats Estimates by a Slim Margin as Stock Edges Lower Nordic American Tankers Limited NAT Q4 2025 Earnings EPS Misses Estimates Stock Declines 908 Devices Q1 2026 Earnings EPS Misses Estimates Significantly Despite Stock Gain SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline